Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    E
  • Enzalutamide

    StatusPipeline

    Therapeutic CategoryOncology

    Polymorphic formAnhydrous form R1

    CAS No.915087-33-1

    View more
  • P
  • Palbociclib

    StatusPipeline

    Therapeutic CategoryOncology

    Polymorphic formcrystal form A

    CAS No.571190-30-2

    View more